Track HealthCare Global Enterprises Limited — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

HealthCare Global Enterprises Limited HCG.NS Open HealthCare Global Enterprises Limited in new tab

527.70 INR
P/E
399.85
EPS
1.33
P/B
8.10
ROE
4.34
Beta
-0.40
Target Price
761.14 INR
Loading chart...
Key Metrics
Earnings dateMay 22, 2026
P/E399.85
EPS1.33
Book Value65.64
Price to Book8.10
Debt/Equity177.91
% Insiders66.593%
Growth
Revenue Growth0.13%
Earnings Growth-0.09%
Estimates
Forward P/E56.83
Forward EPS9.36
Target Mean Price761.14

DCF Valuation

Tweak assumptions to recompute fair value for HealthCare Global Enterprises Limited (HCG.NS)
Currency: INR
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result

Fair Value (DCF)
Current Price
Upside
WACC
Terminal PV
Σ PV of FCFs
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

HealthCare Global Enterprises Limited Logo HealthCare Global Enterprises Limited Analysis (HCG.NS)

India Health Care Official Website Stock

Is HealthCare Global Enterprises Limited a good investment? HealthCare Global Enterprises Limited (HCG.NS) is currently trading at 527.70 INR. Market analysts have a consensus price target of 761.14 INR. This suggests a potential upside from current levels.

In terms of valuation, the stock trades at a P/E ratio of 399.85. This high multiple suggests investors have priced in significant future growth expectations.

Earnings Schedule: HealthCare Global Enterprises Limited is expected to release its next earnings report on May 22, 2026. The market consensus estimate for Forward EPS is 9.36.

Investor FAQ

Does HealthCare Global Enterprises Limited pay a dividend?

No, it does not currently pay a dividend.

What asset class is HealthCare Global Enterprises Limited?

HealthCare Global Enterprises Limited is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

When is the next earnings date?

The next earnings date is projected to be May 22, 2026. The company currently has a trailing EPS of 1.33.

Company Profile

HealthCare Global Enterprises Limited provides medical and healthcare services in India and internationally. The company offers cancer diagnostics services, including genomics and molecular diagnostics, digital PET, preventive oncology, physical examination, laboratory tests, home health services, digital pathology, and CTC detection; treatment services, such as medical oncology and haemato-oncology, radiation and surgical oncology, molecular imaging and theranostics, chemotherapy, robotic surgery, actinium and lutetium therapy, immunotherapy, psycho-oncology, targeted drug therapy, bone marrow transplant, pediatric oncology, organ preservation and reconstructive surgery, endocrine therapy, and liver transplant; and post care services comprising patient care, psychological support, nutrition and dietetics, multidisciplinary rehabilitation, and genetic counselling. It also provides cancer screening, interventional radiology, MRI, nephrology, clinical trial, hormone therapy, hematology, CAR T cell, translational and nuclear medicine, oncodermatology, anaesthesiology, paediatric and gynaecologic oncology, orthopaedic oncology, uro-oncology, infectious diseases, gastrointestinal and thoracic oncology, breast surgical oncology, clinical pharmacology, and pain and palliative services. In addition, the company operates multi-specialty hospitals under the HCG brand that offers inpatient and outpatient treatments with specialties in cardiology, neurology, orthopaedics, gastroenterology, urology, internal medicine and pulmonary, and critical care. Further, it provides oncology diagnostics services, including biomarker and translational research, and clinical research services under the Triesta Sciences brand; and fertility treatment services, including reproductive medicine, assisted reproduction, gynecological endoscopy, and fertility preservation under the Milann brand. HealthCare Global Enterprises Limited was founded in 1989 and is headquartered in Bengaluru, India.

Exchange Ticker
NSI (India) HCG.NS

Dividends

Historical Split Corporate Actions

Trades
Trade History
No trades yet
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion